4.4 Article

Systemic TM4SF5 overexpression in ApcMin/+ mice promotes hepatic portal hypertension associated with fibrosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes

Hyunseung Sun et al.

Summary: The study revealed that TM4SF5 signaling contributes to immune evasion during liver carcinogenesis by suppressing NK cell number and function. Inhibiting TM4SF5 can restore NK cell surveillance, reduce fibrotic and cancerous phenotypes, and prolong survival in liver cancer.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Endocrinology & Metabolism

Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis

Hyejin Lee et al.

Summary: This study investigated the modulation of hepatic fructose metabolism by TM4SF5 and found that it can regulate fructose uptake and lipogenesis by interacting with GLUT8, thereby affecting liver steatosis.

MOLECULAR METABOLISM (2022)

Article Oncology

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models

Dongjoon Ko et al.

Summary: The study found that the antibody Ab27 can significantly inhibit the growth of tumor cells expressing TM4SF5 and reduce the levels of phosphorylated proteins associated with tumor progression. Combination therapy with other drugs can enhance the anti-tumor activity. Humanization can reduce immunogenicity while maintaining anti-tumor activity. These observations are of great significance for the further development of these antibodies as therapeutic agents against liver and colorectal cancers.

MOLECULAR THERAPY-ONCOLYTICS (2022)

Article Oncology

Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression

Jihye Ryu et al.

Summary: The study revealed the crucial role of TM4SF5 in the progression of nonalcoholic steatohepatitis (NASH), including inducing lipid accumulation, inflammatory responses, and fibrosis in liver tissue. TM4SF5, along with signaling pathways involving SIRT1, SREBPs, and SOCS/STAT3, promoted the development of NASH.

JOURNAL OF PATHOLOGY (2021)

Article Oncology

Adenomatous polyposis coli in cancer and therapeutic implications

Olivia Noe et al.

Summary: Inactivating mutations of the APC gene and upregulation of the Wnt signaling pathway play crucial roles in colorectal cancer development, with potential implications in other cancers as well. Research for therapies targeting APC mutations is ongoing, with a focus on identifying effective molecular targets to improve patient outcomes.

ONCOLOGY REVIEWS (2021)

Article Cell Biology

TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment

Eunmi Kim et al.

Summary: The TM4SF5 protein plays a critical role in communication between hepatocytes and macrophages, influencing the inflammatory microenvironment and potentially leading to NAFLD progression.

CELL REPORTS (2021)

Review Gastroenterology & Hepatology

Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma

Fang Wang et al.

Summary: This review summarizes the new proto-oncogenes and tumor suppressor genes identified in hepatocellular carcinoma (HCC) over the past five years, which may inspire the development of novel therapeutic strategies to improve the outcome of HCC patients.

LIVER RESEARCH (2021)

Article Medicine, Research & Experimental

N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application

Haeng Eun Song et al.

Summary: The study revealed that the binding of the TM4SF5 C-terminus to the kinase domain of inactive c-Src leads to its activation. Cell-penetrating peptides containing the TM4SF5 C-terminus can block the interaction of TM4SF5 with c-Src, preventing the initiation and progression of hepatocellular carcinoma.

THERANOSTICS (2021)

Review Oncology

Biomarker-guided therapy for colorectal cancer: strength in complexity

Anita Sveen et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Biochemistry & Molecular Biology

Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex

Youn-Sang Jung et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Review Pharmacology & Pharmacy

CD133: beyond a cancer stem cell biomarker

Amir Barzegar Behrooz et al.

JOURNAL OF DRUG TARGETING (2019)

Review Oncology

The application of ApcMin/+ mouse model in colorectal tumor researches

Junze Ren et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)

Article Gastroenterology & Hepatology

Biology of portal hypertension

Matthew McConnell et al.

HEPATOLOGY INTERNATIONAL (2018)

Article Biochemistry & Molecular Biology

Inactivation of Itf2 promotes intestinal tumorigenesis in ApcMin+ mice

Jessica I. Grill et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Oncology

Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer

Krishnendu Pal et al.

MOLECULAR CANCER THERAPEUTICS (2014)

Article Biochemistry & Molecular Biology

The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation

Oisun Jung et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Review Oncology

Biology and clinical implications of CD133+ liver cancer stem cells

Stephanie Ma

EXPERIMENTAL CELL RESEARCH (2013)

Article Multidisciplinary Sciences

Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells

Yuanyan Wei et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Transmembrane 4 L Six Family Member 5 (TM4SF5) Enhances Migration and Invasion of Hepatocytes for Effective Metastasis

Sin-Ae Lee et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2010)

Article Medicine, Research & Experimental

Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma

Sin-Ae Lee et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Review Oncology

Glycogen synthase kinase-3 beta; A new target in pancreatic cancer?

G. Garcea et al.

CURRENT CANCER DRUG TARGETS (2007)

Review Oncology

Multistep carcinogenesis of the colon in Apc(Min/+) mouse

Yasuhiro Yamada et al.

CANCER SCIENCE (2007)